Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-26

Clinical Trial Update: A Study to See Whether Estrogen Can Slow the Growth of Some ER Positive Breast Cancers [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial aims to determine if estrogen can slow the growth of estrogen receptor-positive breast cancers. The study, sponsored by AHS Cancer C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Estrogen (Estrogen)

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Estrogen Receptor Positive Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING